Gil-Jimenez, Alberto ; van Dorp, Jeroen 
; Contreras-Sanz, Alberto ; van der Vos, Kristan ; Vis, Daniel J. ; Braaf, Linde ; Broeks, Annegien ; Kerkhoven, Ron ; van Kessel, Kim E.M. ; Ribal, María José ; Alcaraz, Antonio ; Wessels, Lodewyk F.A. ; Seiler, Roland ; Wright, Jonathan L. ; Mengual, Lourdes ; Boormans, Joost ; van Rhijn, Bas W.G. ; Black, Peter C. ; van der Heijden, Michiel S.
; Contreras-Sanz, Alberto ; van der Vos, Kristan ; Vis, Daniel J. ; Braaf, Linde ; Broeks, Annegien ; Kerkhoven, Ron ; van Kessel, Kim E.M. ; Ribal, María José ; Alcaraz, Antonio ; Wessels, Lodewyk F.A. ; Seiler, Roland ; Wright, Jonathan L. ; Mengual, Lourdes ; Boormans, Joost ; van Rhijn, Bas W.G. ; Black, Peter C. ; van der Heijden, Michiel S. 
Zusammenfassung
Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy is rec-ommended for patients with muscle-invasive bladder cancer (MIBC). It has been shown that somatic deleterious mutations in ERCC2, gain-of-function mutations in ERBB2, and alterations in ATM, RB1, and FANCC are correlated with pathological response to NAC in MIBC. The objective of this study was to validate these ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric